Cytokinetics (CYTK)Director sold ~$90K

~$90K

Approx. value · 1,780 sh @ $50.42

38K

Holds after · shares reported

Traded

Dec 11, 2024

Filed

Dec 12, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 15, 2024Insider · 1 personInsiders: 2 sales (~$396K)
2. Oct 28, 2024InsiderDirector sold ~$233K of CYTK shares in the open market
3. Oct 30, 2024Insider · 1 personInsiders: 2 sales (~$379K)
4. Nov 1, 2024InsiderCEO sold ~$258K of CYTK shares in the open market
5. Nov 12, 2024Insider · 1 personInsiders: 2 sales (~$371K)
6. Nov 18, 2024InsiderCEO sold ~$253K of CYTK shares in the open market
7. Nov 25, 2024InsiderDirector sold ~$37K of CYTK shares in the open market
8. Nov 26, 2024Insider · 1 personInsiders: 2 sales (~$366K)
9. Dec 2, 2024InsiderCEO sold ~$254K of CYTK shares in the open market
10. Dec 10, 2024Insider · 1 personInsiders: 2 sales (~$370K)
11. Dec 11, 2024 · this disclosureInsiderDirector sold ~$90K of CYTK shares in the open market

What came next

1. Dec 16, 2024InsiderDirector sold ~$36K of CYTK shares in the open market
2. Jan 7, 2025InsiderOfficer sold ~$99K of CYTK shares in the open market
3. Jan 21, 2025InsiderOfficer sold ~$92K of CYTK shares in the open market
4. Feb 4, 2025InsiderOfficer sold ~$96K of CYTK shares in the open market
5. Feb 18, 2025InsiderOfficer sold ~$92K of CYTK shares in the open market
6. Mar 3, 2025Insider · 3 peopleInsiders: 3 sales (~$528K)
7. Mar 4, 2025Insider · 2 peopleInsiders: 2 sales (~$123K)
8. Mar 5, 2025InsiderCEO sold ~$1.08M of CYTK shares in the open market
9. Mar 6, 2025Insider · 3 peopleInsiders: 3 sales (~$1.2M)
10. Mar 13, 2025InsiderOfficer sold ~$1.17M of CYTK shares in the open market
11. Mar 14, 2025InsiderOfficer sold ~$4.5K of CYTK shares in the open market
12. Mar 17, 2025Insider · 3 peopleInsiders: 5 sales (~$2.9M)
13. Mar 18, 2025InsiderOfficer sold ~$87K of CYTK shares in the open market
14. Mar 31, 2025InsiderCEO sold ~$611K of CYTK shares in the open market
15. Apr 3, 2025InsiderDirector sold ~$18K of CYTK shares in the open market
16. Apr 7, 2025InsiderOfficer sold ~$103K of CYTK shares in the open market
17. Apr 8, 2025InsiderOfficer sold ~$72K of CYTK shares in the open market
18. Apr 10, 2025InsiderCEO sold ~$184K of CYTK shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cytokinetics

For Cytokinetics, OQRO holds 18 insider filings (SEC Form 4 or Form 144) and 11 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CYTK page.

Other recent filings by John T Henderson, Director

• SEC Form 4 at Cytokinetics (CYTK)May 5, 2026
• SEC Form 4 at Cytokinetics (CYTK)Dec 2, 2025
• SEC Form 4 at Cytokinetics (CYTK)Apr 16, 2025

The full history of John T Henderson, Director is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cytokinetics

• SEC Form 4Oct 6, 2026
• SEC Form 4Sep 28, 2026
• SEC Form 4Sep 22, 2026
• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 15, 2026
• SEC Form 4Sep 15, 2026

Everything OQRO holds on this company is on its CYTK page.